Repeated Ethanol but not Phencyclidine Impairs Spontaneous Alternation Behaviour in the Y-Maze

Basic and Clinical Pharmacology and Toxicology

Volumn 110, Issue 4, 2012, Pages 347-352

  Götesson, Joacim ^a   Ericson, Mia ^a   Söderpalm, Bo ^a,b   Pickering, Chris ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PHENCYCLIDINE; SODIUM CHLORIDE;

ADOLESCENT; ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BRAIN DYSFUNCTION; CONTROLLED STUDY; IMMOBILIZATION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECOGNITION; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ETHANOL; HALLUCINOGENS; MALE; MAZE LEARNING; MOTOR ACTIVITY; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 84858620518     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00819.x     Document Type: Article

References (41)

1. Moselhy HF, Georgiou G, Kahn A. Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol 2001;36:357-68.
2. Zinn S, Stein R, Swartzwelder HS. Executive functioning early in abstinence from alcohol. Alcohol Clin Exp Res 2004;28:1338-46.
3. Chanraud S, Martelli C, Delain F, Kostogianni N, Douaud G, Aubin HJ et al. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 2007;32:429-38.
4. De Bellis MD, Narasimhan A, Thatcher DL, Keshavan MS, Soloff P, Clark DB. Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res 2005;29:1590-600.
5. Rogers RL, Meyer JS, Shaw TG, Mortel KF. Reductions in regional cerebral blood flow associated with chronic consumption of alcohol. J Am Geriatr Soc 1983;31:540-3.
6. Clarke J, Haughton H. A study of intellectual impairment and recovery rates in heavy drinkers in Ireland. Br J Psychiatry 1975;126:178-84.
7. Ron MA, Acker W, Shaw GK, Lishman WA. Computerized tomography of the brain in chronic alcoholism: a survey and follow-up study. Brain 1982;3:497-514.
8. Blume AW, Schmaling KB, Marlatt GA. Memory, executive cognitive function, and readiness to change drinking behavior. Addict Behav 2005;30:301-14.
9. Ihara H, Berrios GE, London M. Group and case study of the dysexecutive syndrome in alcoholism without amnesia. J Neurol Neurosurg Psychiatry 2000;68:731-7.
10. Allen RM, Young SJ. Phencyclidine-induced psychosis. Am J Psychiatry 1978;135:1081-4.
11. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994;51:199-214.
12. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999;20:201-25.
13. Wang CZ, Yang SF, Xia Y, Johnson KM. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology 2008;33:2442-55.
14. Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 2009;56:1001-9.
15. Abdul-Monim Z, Neill JC, Reynolds GP. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol 2007;21:198-205.
16. Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 2003;28:265-75.
17. Pickering C, Chau PP, Soderpalm B, Ericson M. Ethanol and phencyclidine interact with respect to nucleus accumbens dopamine release: differential effects of administration order and pretreatment protocol. Front Behav Neurosci 2010;4:32.
18. Hundt W, Danysz W, Holter SM, Spanagel R. Ethanol and N-methyl-D-aspartate receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology (Berl) 1998;135:44-51.
19. Doremus-Fitzwater TL, Varlinskaya EI, Spear LP. Motivational systems in adolescence: possible implications for age differences in substance abuse and other risk-taking behaviors. Brain Cogn 2009;72:114-23.
20. Roberts WW, Dember WN, Brodwick M. Alternation and exploration in rats with hippocampal lesions. J Comp Physiol Psychol 1962;55:695-700.
21. Means LW, Leander JD, Isaacson RL. The effects of hippocampectomy on alternation behavior and response of novelty. Physiol Behav 1971;6:17-22.
22. Stevens R, Cowey A. Effects of dorsal and ventral hippocampal lesions on spontaneous alternation, learned alternation and probability learning in rats. Brain Res 1973;52:203-24.
23. Divac I, Wikmark RGE, Gade A. Spontaneous alternation in rats with lesions in the frontal lobe: an extension of the frontal lobe syndrome. Physiol Psychol 1975;3:39-42.
24. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 2002;26:91-104.
25. Delatour B, Gisquet-Verrier P. Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat. Behav Neurosci 1996;110:1282-98.
26. Molander A, Soderpalm B. Accumbal strychnine-sensitive glycine receptors: an access point for ethanol to the brain reward system. Alcohol Clin Exp Res 2005;29:27-37.
27. Pickering C, Liljequist S. Cue-induced behavioural activation: a novel model of alcohol craving? Psychopharmacology (Berl) 2003;168:307-13.
28. Crews FT, Braun CJ, Hoplight B, Switzer RC III, Knapp DJ. Binge ethanol consumption causes differential brain damage in young adolescent rats compared with adult rats. Alcohol Clin Exp Res 2000;24:1712-23.
29. Leasure JL, Nixon K. Exercise neuroprotection in a rat model of binge alcohol consumption. Alcohol Clin Exp Res 2010;34:404-14.
30. Evrard SG, Duhalde-Vega M, Tagliaferro P, Mirochnic S, Caltana LR, Brusco A. A low chronic ethanol exposure induces morphological changes in the adolescent rat brain that are not fully recovered even after a long abstinence: an immunohistochemical study. Exp Neurol 2006;200:438-59.
31. Hargreaves GA, Quinn H, Kashem MA, Matsumoto I, McGregor IS. Proteomic analysis demonstrates adolescent vulnerability to lasting hippocampal changes following chronic alcohol consumption. Alcohol Clin Exp Res 2009;33:86-94.
32. Morris SA, Eaves DW, Smith AR, Nixon K. Alcohol inhibition of neurogenesis: a mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model. Hippocampus 2010;20:596-607.
33. Floresco SB, Jentsch JD. Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 2011;36:227-50.
34. Maurice T, Su TP, Parish DW, Nabeshima T, Privat A. PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav 1994;49:859-69.
35. Schlumberger C, Schafer D, Barberi C, More L, Nagel J, Pietraszek M et al. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition. Behav Pharmacol 2009;20:56-66.
36. Beninger RJ, Beuk J, Banasikowski TJ, van Adel M, Boivin GA, Reynolds JN. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding. Behav Pharmacol 2010;21:1-10.
37. Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL et al. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 2010;128:419-32.
38. Redrobe JP, Bull S, Plath N. Translational aspects of the novel object recognition task in rats abstinent following sub-chronic treatment with phencyclidine (PCP): effects of modafinil and relevance to cognitive deficits in schizophrenia. Front Psychiatry 2010;1:146.
39. Cowell RA, Bussey TJ, Saksida LM. Components of recognition memory: dissociable cognitive processes or just differences in representational complexity? Hippocampus 2010;20:1245-62.
40. Winters BD, Saksida LM, Bussey TJ. Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval. Neurosci Biobehav Rev 2008;32:1055-70.
41. Vann SD, Albasser MM. Hippocampus and neocortex: recognition and spatial memory. Curr Opin Neurobiol 2011;21:440-5.